MA44965A - Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3 - Google Patents
Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3Info
- Publication number
- MA44965A MA44965A MA044965A MA44965A MA44965A MA 44965 A MA44965 A MA 44965A MA 044965 A MA044965 A MA 044965A MA 44965 A MA44965 A MA 44965A MA 44965 A MA44965 A MA 44965A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical compositions
- pyridinyl derivatives
- aoc3 inhibitors
- aoc3
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne de nouveaux dérivés de pyridinyle de formule (i) dans laquelle r1 et a sont tels que définis dans la description et les revendications, leur utilisation en tant que médicaments, des procédés pour leur utilisation thérapeutique et des compositions pharmaceutiques les contenant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16169356 | 2016-05-12 | ||
PCT/EP2017/060890 WO2017194453A1 (fr) | 2016-05-12 | 2017-05-08 | Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3 |
Publications (2)
Publication Number | Publication Date |
---|---|
MA44965A true MA44965A (fr) | 2019-03-20 |
MA44965B1 MA44965B1 (fr) | 2021-02-26 |
Family
ID=55967162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA44965A MA44965B1 (fr) | 2016-05-12 | 2017-05-08 | Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3 |
Country Status (32)
Country | Link |
---|---|
US (1) | US9926292B2 (fr) |
EP (1) | EP3455216B1 (fr) |
JP (1) | JP6639702B2 (fr) |
KR (1) | KR20190003995A (fr) |
CN (1) | CN109153664B (fr) |
AR (1) | AR108462A1 (fr) |
AU (1) | AU2017262707B2 (fr) |
CA (1) | CA3023805A1 (fr) |
CL (1) | CL2018003158A1 (fr) |
CO (1) | CO2018012020A2 (fr) |
CY (1) | CY1123744T1 (fr) |
DK (1) | DK3455216T3 (fr) |
EA (1) | EA037188B1 (fr) |
ES (1) | ES2844926T3 (fr) |
HR (1) | HRP20202078T1 (fr) |
HU (1) | HUE053312T2 (fr) |
IL (1) | IL262662B (fr) |
JO (1) | JOP20170115B1 (fr) |
LT (1) | LT3455216T (fr) |
MA (1) | MA44965B1 (fr) |
MX (1) | MX2018013701A (fr) |
PE (1) | PE20190151A1 (fr) |
PH (1) | PH12018502376B1 (fr) |
PL (1) | PL3455216T3 (fr) |
PT (1) | PT3455216T (fr) |
RS (1) | RS61256B1 (fr) |
SA (1) | SA518400393B1 (fr) |
SG (1) | SG11201809687TA (fr) |
SI (1) | SI3455216T1 (fr) |
TW (1) | TWI746551B (fr) |
UA (1) | UA121930C2 (fr) |
WO (1) | WO2017194453A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021520394A (ja) * | 2018-04-17 | 2021-08-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 医薬組成物、処置方法及びその使用 |
CN112789277B (zh) * | 2018-10-22 | 2022-11-04 | 广东东阳光药业有限公司 | 胍类衍生物及其用途 |
CA3112510A1 (fr) * | 2018-10-29 | 2020-05-07 | Boehringer Ingelheim International Gmbh | Derives de pyridinyl sulfonamide, compositions pharmaceutiques et leurs utilisations |
BR112022007974A2 (pt) | 2019-10-29 | 2022-07-12 | Eccogene Shanghai Co Ltd | Inibidores de ssao e uso dos mesmos |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19518073A1 (de) * | 1995-05-17 | 1996-11-21 | Hoechst Ag | Substituierte Benzyloxycarbonylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP1663204B1 (fr) * | 2003-08-29 | 2014-05-07 | Exelixis, Inc. | Modulateurs c-kit et leurs procedes d'utilisation |
EP1786792B1 (fr) * | 2004-07-27 | 2009-04-08 | Astellas Pharma Inc. | Derives de thiazole presentant une activite d'inhibition de la vap-1 |
CN102498091B (zh) * | 2009-09-16 | 2014-03-05 | 安斯泰来制药株式会社 | 甘氨酸化合物 |
MX354458B (es) * | 2011-03-15 | 2018-03-06 | Astellas Pharma Inc | Compuesto de guanidina. |
RU2733951C9 (ru) | 2015-08-06 | 2020-12-22 | Убе Индастриз, Лтд. | Замещенные производные гуанидина |
-
2017
- 2017-05-08 LT LTEP17721706.4T patent/LT3455216T/lt unknown
- 2017-05-08 KR KR1020187035976A patent/KR20190003995A/ko active IP Right Grant
- 2017-05-08 EA EA201892539A patent/EA037188B1/ru not_active IP Right Cessation
- 2017-05-08 JP JP2018559351A patent/JP6639702B2/ja active Active
- 2017-05-08 MX MX2018013701A patent/MX2018013701A/es unknown
- 2017-05-08 US US15/588,739 patent/US9926292B2/en active Active
- 2017-05-08 DK DK17721706.4T patent/DK3455216T3/da active
- 2017-05-08 HU HUE17721706A patent/HUE053312T2/hu unknown
- 2017-05-08 CN CN201780027576.9A patent/CN109153664B/zh active Active
- 2017-05-08 CA CA3023805A patent/CA3023805A1/fr active Pending
- 2017-05-08 EP EP17721706.4A patent/EP3455216B1/fr active Active
- 2017-05-08 RS RS20201583A patent/RS61256B1/sr unknown
- 2017-05-08 SG SG11201809687TA patent/SG11201809687TA/en unknown
- 2017-05-08 ES ES17721706T patent/ES2844926T3/es active Active
- 2017-05-08 PT PT177217064T patent/PT3455216T/pt unknown
- 2017-05-08 UA UAA201812102A patent/UA121930C2/uk unknown
- 2017-05-08 MA MA44965A patent/MA44965B1/fr unknown
- 2017-05-08 AU AU2017262707A patent/AU2017262707B2/en not_active Ceased
- 2017-05-08 PL PL17721706T patent/PL3455216T3/pl unknown
- 2017-05-08 PE PE2018002340A patent/PE20190151A1/es unknown
- 2017-05-08 WO PCT/EP2017/060890 patent/WO2017194453A1/fr unknown
- 2017-05-08 SI SI201730584T patent/SI3455216T1/sl unknown
- 2017-05-11 JO JOP/2017/0115A patent/JOP20170115B1/ar active
- 2017-05-11 TW TW106115558A patent/TWI746551B/zh not_active IP Right Cessation
- 2017-05-11 AR ARP170101262A patent/AR108462A1/es unknown
-
2018
- 2018-10-29 IL IL262662A patent/IL262662B/en unknown
- 2018-11-06 CO CONC2018/0012020A patent/CO2018012020A2/es unknown
- 2018-11-07 SA SA518400393A patent/SA518400393B1/ar unknown
- 2018-11-08 CL CL2018003158A patent/CL2018003158A1/es unknown
- 2018-11-12 PH PH12018502376A patent/PH12018502376B1/en unknown
-
2020
- 2020-12-30 HR HRP20202078TT patent/HRP20202078T1/hr unknown
-
2021
- 2021-01-19 CY CY20211100039T patent/CY1123744T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50240B1 (fr) | Modulateurs de la protéine régulatrice de la conductance transmembranaire de la fibrose kystique et procédés d'utilisation | |
MA42230B1 (fr) | Dérivés bicycliques, leur procédé de préparation, et compositions pharmaceutiques les contenant | |
MA42231B1 (fr) | Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant | |
MA45222A (fr) | Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
MA38099A1 (fr) | Des nouveaux composes triazolopyrazines substitues inhibiteurs des brd4 | |
MA44851A (fr) | Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations | |
MA40111B1 (fr) | Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1 | |
MA42239B1 (fr) | Nouveaux dérivés d'hydroxyester, leur procédé de préparation et compositions pharmaceutiques les contenant | |
MA40893B1 (fr) | Dérivés de phényltriazole à substitution hydroxyalkyle et utilisations associées | |
MA45782B1 (fr) | Modulateurs du récepteur de cxcr7 pipéridine | |
MA34545B1 (fr) | Co-cristaux et sels d'inhibiteurs de ccr3 | |
MA40768A (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
MA38287B1 (fr) | Nouveaux dérivés aminopyrazine pour le traitement ou la prévention du cancer | |
MA44965A (fr) | Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3 | |
MA40875A (fr) | 2,4-diamino-quinoléine substituée servant de nouveaux agents anticancéreux | |
MA46229B1 (fr) | Composés d'hétéroaryle carboxamide en tant qu'inhibiteurs de ripk2 | |
MA49127B1 (fr) | Dérivés d'indole n-substitués | |
MA37742B1 (fr) | Dérivés d'oestra-1,3,5 (10), 16-tétraène substitués en position 3, leurs procédés de préparation, préparations pharmaceutiques les contenant, et leur utilisation pour la fabrication de médicaments | |
MA38190A2 (fr) | Inhibiteurs d'autotaxine | |
MA38679B1 (fr) | Modulateurs du récepteur de cxcr7 | |
MA40366A (fr) | Dérivés de tétrahydroquinoline à titre d'inhibiteurs des bromodomaines | |
MA43913B1 (fr) | Modulateurs allostériques positifs du récepteur m1 muscarinique | |
MA39229A1 (fr) | Pyrrolidines, térahydrofuranes et cyclopentanes substitués utiles en tant qu'antagonistes des récepteurs des orexines | |
MA41174B1 (fr) | Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta | |
TN2014000371A1 (fr) | Dérivés macrocycliques pour le traitement de maladies prolifératives |